| The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma Nature genetics 46 (5), 444-450, 2014 | 1033 | 2014 |
| Novel mutations target distinct subgroups of medulloblastoma G Robinson, M Parker, TA Kranenburg, C Lu, X Chen, L Ding, TN Phoenix, ... Nature 488 (7409), 43-48, 2012 | 916 | 2012 |
| Vismodegib exerts targeted efficacy against recurrent sonic hedgehog–subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032 GW Robinson, BA Orr, G Wu, S Gururangan, T Lin, I Qaddoumi, ... Journal of Clinical Oncology 33 (24), 2646, 2015 | 460 | 2015 |
| Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial J Fangusaro, A Onar-Thomas, TY Poussaint, S Wu, AH Ligon, ... The lancet oncology 20 (7), 1011-1022, 2019 | 373 | 2019 |
| Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma BS Paugh, A Broniscer, C Qu, CP Miller, J Zhang, RG Tatevossian, ... Journal of clinical oncology 29 (30), 3999, 2011 | 357 | 2011 |
| A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study A Banerjee, RI Jakacki, A Onar-Thomas, S Wu, T Nicolaides, ... Neuro-oncology 19 (8), 1135-1144, 2017 | 298 | 2017 |
| Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study SL Palmer, C Armstrong, A Onar-Thomas, S Wu, D Wallace, MJ Bonner, ... Journal of Clinical Oncology 31 (28), 3494, 2013 | 256 | 2013 |
| Histone H3. 3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression JD Larson, LH Kasper, BS Paugh, H Jin, G Wu, CH Kwon, Y Fan, TI Shaw, ... Cancer cell 35 (1), 140-155. e7, 2019 | 242 | 2019 |
| Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas BS Paugh, X Zhu, C Qu, R Endersby, AK Diaz, J Zhang, DA Bax, ... Cancer research 73 (20), 6219-6229, 2013 | 229 | 2013 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 228 | 2018 |
| Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study S Gururangan, SN Chi, T Young Poussaint, A Onar-Thomas, ... Journal of Clinical Oncology 28 (18), 3069-3075, 2010 | 227 | 2010 |
| cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation DW Ellison, C Hawkins, DTW Jones, A Onar-Thomas, SM Pfister, ... Acta neuropathologica 137, 683-687, 2019 | 220 | 2019 |
| Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study RI Jakacki, PC Burger, T Zhou, EJ Holmes, M Kocak, A Onar, J Goldwein, ... Journal of clinical oncology 30 (21), 2648, 2012 | 219 | 2012 |
| Tool breakage detection using support vector machine learning in a milling process S Cho, S Asfour, A Onar, N Kaundinya International Journal of Machine Tools and Manufacture 45 (3), 241-249, 2005 | 217 | 2005 |
| Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, ... The Lancet Oncology 19 (6), 768-784, 2018 | 201 | 2018 |
| Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study M Fouladi, CF Stewart, J Olson, LM Wagner, A Onar-Thomas, M Kocak, ... Journal of Clinical Oncology 29 (26), 3529, 2011 | 168 | 2011 |
| Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study S Gururangan, J Fangusaro, TY Poussaint, RE McLendon, ... Neuro-oncology 16 (2), 310-317, 2014 | 158 | 2014 |
| Multi-organ mapping of cancer risk L Zhu, D Finkelstein, C Gao, L Shi, Y Wang, D López-Terrada, K Wang, ... Cell 166 (5), 1132-1146. e7, 2016 | 156 | 2016 |
| Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03) A Gajjar, GW Robinson, KS Smith, T Lin, TE Merchant, M Chintagumpala, ... Journal of Clinical Oncology 39 (7), 822, 2021 | 136 | 2021 |
| Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss H Xu, GW Robinson, J Huang, JYS Lim, H Zhang, JK Bass, A Broniscer, ... Nature genetics 47 (3), 263-266, 2015 | 134 | 2015 |
